Clinical Trials Browser

Urogenital Diseases, Breast Neoplasms, Gastrointestinal Neoplasms, Lung Neoplasms, Lymphoma, Melanoma, Neoplasms, Sarcoma, Spinal Diseases, Spinal Neoplasms

NCT05845671 2026-01-14

Amivantamab With Tyrosine Kinase Inhibitors (TKI) for Advanced NSCLC With ALK, ROS1, or RET Alterations

Phase 1/2 Active not recruiting

12 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00618553 2026-01-12

Effect of Pulmonary Rehabilitation on Surgical Outcomes in the Cancer Setting

Phase 2 Active not recruiting

75 enrolled

Thoracic

Lung Neoplasms

NCT04081779 2026-01-09

Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT Study

Phase NA Active not recruiting

261 enrolled

BreastGastrointestinalGenitourinaryLymphoidThoracic

Breast Neoplasms, Lung Neoplasms, Lymphoma, Prostatic Neoplasms, Colorectal Neoplasms

Clinical Trials

OTC-RATS

IPF-LC-IO

Molecular Imaging of Fibroblast Activation Protein Expression Using Labeled Technetium-99m HYNIC-FAPI

Feasibility of Targeted Bronchial Washing for Molecular Testing by Next Generation Sequencing in Early-stage Lung Cancer

Necitumumab and Trastuzumab in Combination With Osimertinib for the Treatment of Refractory Epidermal Growth Factor Receptor (EGFR)-Mutated Stage IV Non-small Cell Lung Cancer

Comparison of Imaging Characteristics of uEXPLORER and Conventional PET/CT in Patients With Lung Cancer, Lymphoma, and Melanoma

MAGELLAN

PUMA

Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma

Stereotactic Radiosurgery for the Treatment of Patients With Small Cell Lung Cancer Brain Metastasis

Minnelide and Osimertinib for the Treatment of Advanced EGFR Mutated Non-Small Cell Lung Cancer

Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant Cancers

iSMART

Treating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation Therapy

Risk and Benefits of Electronic Cigarettes to Older Smokers at High Risk for Lung Cancer

First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide

Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers

Efficacy and Safety of Standard of Care Plus Durvalumab in Patients With Limited Disease Small Cell Lung Cancer (DOLPHIN)

Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal Cancer

Oncology Episode Payment Model in Hawaii

Multimedia Self-Management Intervention for Lung Cancer Surgery Family Caregivers and Patients

Ensartinib, Carboplatin, Pemetrexed and Bevacizumab for the Treatment of Stage IIIC or IV or Recurrent ALK-Positive Non-small Cell Lung Cancer

MK-3475 and Gemcitabine in Non-Small Cell Lung Cancer (NSCLC)

A Phase 1/2 Study of KSQ-001EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate the SOCS1 Gene, in Patients With Select Advanced Solid Tumors

All-Trans Retinoic Acid (ATRA) and Atezolizumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer

Evaluating the Impact of a Virtually Supervised Exercise Intervention and Group Counseling on Inflammation and the Microbiome of Smokers at High Risk for Lung Cancer, BE FIT Trial

Niraparib, Temozolomide and Atezolizumab in Treating Patients With Advanced Solid Tumors and Extensive-Stage Small Cell Lung Cancer With a Complete or Partial Response to Platinum-Based First-Line Chemotherapy

WSD0922-FU for the Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System Metastases

Ceritinib Plus Docetaxel in ALK-Negative, EGFR WT Advanced NSCLC

FLAR-4DCT

LIGHTSABR

EBUS-Suction

Clinician-Patient Communication in Lung Cancer Care

Single Fraction Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Non-small Cell Lung Cancer

DoceRamPem

VALKIM

Subcutaneous Atezolizumab for the Treatment of Non-small Cell Lung Cancer

Implementation of a System-level Tobacco Treatment Intervention

A Nurse-Led Intervention for Fear of Progression in Advanced Cancer

CONNECT

Increasing Adherence to Lung Cancer Screening

OPTIMAL

Safety & Efficacy of Consolidative Hypofractionated Radiation Therapy for Boosting Residual Lung Cancer With Durvalumab

Empowering Hispanic Patients' Lung Cancer Screening Uptake (Empower Latinx)

Pilot Study of SGRT Alone vs. SGRT With Fiducials for Breath Hold SBRT tx of the Lung

Trametinib and Pembrolizumab in Treating Patients With Recurrent Non-small Cell Lung Cancer That Is Metastatic, Unresectable, or Locally Advanced

Evaluation of a Novel CT-On-Rails or Trilogy Stereotactic Spine Radiotherapy System (SSRS)

Amivantamab With Tyrosine Kinase Inhibitors (TKI) for Advanced NSCLC With ALK, ROS1, or RET Alterations

Effect of Pulmonary Rehabilitation on Surgical Outcomes in the Cancer Setting

Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT Study